(Q62110990)

English

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Study of Total Marrow Irradiation, Busulfan, and Alpha-Interferon Followed by Allogeneic Peripheral Blood Stem Cell or Marrow Transplantation for Treatment of Patients With Advanced Multiple Myeloma. (English)

0 references

0 references

0 references

United States of America

0 references

start time

December 1997

0 references

research intervention

interferon-alpha

0 references

busulfan

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Fred Hutchinson Cancer Research Center

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00003195

0 references

(Q62110990)

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)